An international team of researchers co-led by John Landers, PhD, has identified KIF5A as a new gene associated with the development of amyotrophic lateral sclerosis. The discovery, published in the journal Neuron, advances the understanding of what causes ALS and further implicates the role of cytoskeletal defects in the axon as a common factor in the disease.
The annual U.S. News & World Report rankings of the best graduate schools names UMass Medical School in the top 10 percent nationwide in primary care, coming in 14th among 144 medical schools and 33 schools of osteopathic medicine surveyed by the weekly news magazine in its 2019 edition of the “Best Graduate Schools.”
Members of the School of Medicine Class of 2018 at UMass Medical School simultaneously ripped open their envelopes from the National Resident Matching Program on Match Day, as they learned where they will begin their medical careers.
Five people will represent the UMass ALS Cellucci Fund in the 2018 Boston Marathon to raise awareness of and funds for breakthrough ALS research underway at UMass Medical School.
Nancy Morris, PhD, ANP, is the 2018 recipient of the ANA Massachusetts Excellence in Nursing Education Award recognizing nurse educators who use innovative approaches to facilitate learning and professional development to advance quality patient care across the commonwealth.
Guangping Gao, PhD, spoke with the Telegram & Gazette about promising research underway by 40 faculty of the Li Weibo Institute for Rare Diseases Research at UMass Medical School.
Devyn Oliver, a PhD student in the Graduate School of Biomedical Sciences, has received the prestigious Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship from the National Institute of Neurological Disorders and Stroke.
An innovative sibling support program founded and directed by Emily Rubin of the Eunice Kennedy Shriver Center at UMass Medical School strives to decrease trauma and build resiliency among family members of psychiatrically hospitalized youth and young adults.
The new vaccine for shingles—now recommended for all healthy adults age 50 and older—is significantly more effective than the earlier vaccine, according to UMass Medical School immunologist Robert Finberg, MD.
The genome of the cabbage looper, a common vegetable pest, has been assembled by scientists working in the lab of Phillip Zamore, PhD, at UMass Medical School. The cabbage looper genome is an important new model system for studying insecticide resistance and small RNAs.